Servier Parties acquisition of Day One Biopharmaceuticals, Inc.

Servier Parties completed its acquisition of Day One Biopharmaceuticals, Inc. on 2026-04-23, according to the Form 8-K Day One Biopharmaceuticals, Inc. filed with the SEC on 2026-04-23. The filing's Item 2.01 states no aggregate dollar price. Day One Biopharmaceuticals, Inc. filed the report because the deal made it part of Servier Parties.

Want the whole picture on Servier Parties?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Servier Parties: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Servier Parties covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

What the filing says

Following the consummation of the Offer, on April 23, 2026, the Servier Parties completed the acquisition of the Company, pursuant to the terms and conditions of the Merger Agreement, through the merger of Purchaser with and into the Company, and without a meeting of stockholders of the Company in accordance with Section 251(h) of the General Corporation Law of the State of Delaware (the " DGCL "), with the Company continuing as the surviving corporation (the " Surviving Corporation ") and a wholly owned subsidiary of Parent (the " Merger ").

More from the filing

As previously reported in the Current Report on Form 8-K filed on March 6, 2026, with the U.S. Securities and Exchange Commission (the " SEC "), on March 6, 2026, Servier Pharmaceuticals LLC, a Delaware limited liability company (" Parent "), Servier Detroit Inc., a Delaware corporation and a wholly owned subsidiary of Parent (" Purchaser "), Day One Biopharmaceuticals, Inc., a Delaware corporation (the " Company "), and Servier S.A.S., a French soci t par actions simplifi e, solely as a guarantor (" Guarantor " and together with Parent and Purchaser, the " Servier Parties "), entered into an

All capitalized terms used but not otherwise defined herein have the meanings given to such terms in the Merger Agreement.

At one minute past 11:59 p.m., Eastern Time, on April 22, 2026 (the " Expiration Time "), the Offer expired and was not further extended.

Quoted from Day One Biopharmaceuticals, Inc.'s Form 8-K.

This is the only completed acquisition Servier Parties reported under Item 2.01 in the last twelve months, as far as the filings of the companies it bought show.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days of completing a significant acquisition or disposition of assets, under Item 2.01 of the report. The acquired company sometimes files one too, when the deal makes it a subsidiary of the buyer.

Every fact on this page is taken from one of those filings and linked to it: which company acquired which, the date the filing gives for completion, and the price when the filing states one in dollars, shown next to the sentence that states it. A filing states what was bought and on what terms; it rarely states why, and neither does this page.

All recent acquisitions